Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-010164
Filing Date
2020-04-29
Accepted
2020-04-29 17:07:28
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10011381x2_defa14a.htm DEFA14A 58135
2 nc10011381x2_nc01.jpg GRAPHIC 599848
3 nc10011381x2_nc02.jpg GRAPHIC 917123
4 nc10011381x2_nc03.jpg GRAPHIC 217409
5 nc10011381x2_nc04.jpg GRAPHIC 67531
  Complete submission text file 0001140361-20-010164.txt   2347190
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37568 | Film No.: 20831459
SIC: 2834 Pharmaceutical Preparations